Subscribe to stay informed!
In the coming days when Endo International closes on its $2.6 billion buyout of the successful men’s health specialty biopharmaceutical company just up…
Auxilium Pharmaceuticals of Chesterbrook says its merger with Canadian biotechnology firm QLT stands firm and it is rejecting Endo International’s proposal to acquire all…
Approximately 190 Auxilium Pharmaceuticals employees are out of a job after sales of the company’s flagship testosterone replacement therapy drug went limp.
In response…
Auxilium Pharmaceuticals, Inc. of Chesterbrook has merged with QLT, Inc. of Vancouver, British Columbia.
QLT is a biotechnology company focused on developing innovative ophthalmology products…
More trying times for Auxilium Pharmaceuticals, Inc. of Chesterbrook?
The specialty biopharmaceutical company on June 2nd announced the impending departure of James E. Fickenscher, the…
Representatives from Auxilium Pharmaceuticals, Inc. of Chesterbrook rang the Nasdaq opening bell on Feb. 26 and also announced to investors solid financial results for 2013…
Before we send you to this site, please subscribe to our daily newsletter.